Home / Insights Enterprise Newsletter / Insights for: Buprenorphine for Opioid Use Disorder, New Training Products, Latest COVID-19 Resources, New CE for June, and more

Improving Access to Buprenorphine for Opioid Use Disorder

Read TRC Healthcare Insights, a newsletter delivering the latest in emerging clinical pharmacy leadership trends straight to your inbox. In each edition, get a roundup of articles, clinical resources, and tools from across TRC products to help your pharmacy teams address the most pressing and timely issues in medication management.

Pain Point: Many patients lack access to treatment for opioid use disorder. In fact, about 40% of U.S. counties have no certified buprenorphine prescribers. Plus COVID-19 has amplified problems, causing disruptions in care. Previously, prescribers had to complete 8 to 24 training hours to get an “X” DEA number to prescribe buprenorphine for opioid use disorder. Now physicians, plus NPs and PAs in most states, can get an X number and treat up to 30 patients at a time by simply applying online.

Solution: Our Prescriber’s Letter article provides guidance to prescribers about how to get started with getting an X number. It also gives clear-cut, practical approaches for initiating therapy. Our Pharmacist’s Letter and Pharmacy Technician’s Letter articles provide advice for pharmacies to help minimize stigma and reduce dispensing barriers. Our Hospital Pharmacist’s Letter article gives best practices for managing transitions of care with buprenorphine products. Our FAQ, Management of Opioid Use Disorder, describes how med options stack up, and our Buprenorphine Quick Start Guide is a practical tool for clinicians who want to jump on board with prescribing buprenorphine.

This month’s Insights also highlights our most popular charts from each of our products, as well as the latest COVID-19 resources that are available. In addition, Insights keeps you posted on TRC Healthcare product releases and updates (like PTU Elite: Hazardous Drugs, and more).

You’ll also get details on freshly released CE/CME courses and can’t-miss webinars.

New CE courses include:

  • Treating Patients with Kidney Disease
  • Managing Opioids in the Community Setting
  • Acute Migraine Management
  • An Overview of Cystic Fibrosis for Pharmacists
  • Behind the Clotting Scene: The Coagulation Cascade

Need timely, concise updates for your pharmacy teams on topics like buprenorphine, COVID-19 treatments, and more? Learn more about Enterprise solutions from TRC >>

Subscribe to Insights Newsletter

Want updates like these delivered straight into your inbox? Subscribe to the Insights monthly newsletter today. Click below, then scroll  to “TRC News and Special Offers” and check the “Insights Enterprise Newsletter” box.